George Dailey is an Endocrinology/Metabolic physician affiliated with Scripps Whittier Diabetes Institute. OpenAlex indexes 96 publications with 6,151 citations (h-index 34).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10666 N Torrey Pines Rd
La Jolla, CA 920371027
Telephone
858-554-7876Registry record last updated 9 Jul 2007.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Horizon Therapeutics plcProgram year20221 payment
- SANOFI-AVENTIS U.S. LLCProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
75.4%Insulin Analog22.2%Toujeo Solostar25%Lantus Solostar22%Lantus17%Humalog15%Humalog Kwikpen U-10012%Tresiba Flextouch U-1009%Part D<11 patientsBiguanide (metformin)15.5%Metformin Hcl56%Metformin Hcl Er44%Part D≥28 patients+ 5 more classes in this area
Hormonal (systemic)
12.5%l-Thyroxine12.5%Levothyroxine Sodium69%Synthroid32%Part D<11 patientsCardiovascular
12.1%Statin10.2%Atorvastatin Calcium63%Simvastatin37%Part D<11 patientsAngiotensin receptor blocker (ARB)1.9%Losartan Potassium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1985–1997 per NIH RePORTER. The latest:
- PHASE III TRIAL OF HUMAN PROINSULIN IN TYPE I AND TYPE II DIABETES
Scripps Clinic and Research Foundation
FY1989M01RR000833 - GLYBURIDE AND GLIPIZIDE IN NON-INSULIN DEPENDENT DIABETES
Scripps Clinic and Research Foundation
FY1989M01RR000833
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”